Keyphrases
Chagas Disease
100%
Thromboinflammation
100%
Hepatocyte nuclear Factor 4α (HNF4α)
100%
Coagulation Factors
36%
Trypanosoma Cruzi (T. cruzi)
36%
Gene Expression
18%
Cardiac Disease
18%
Chagas
18%
Nucleoprotein
18%
Histone Epigenetics
18%
Expression Activity
18%
Three-level
18%
Longitudinal Change
9%
Thrombophilia
9%
Nucleoprotein Complex
9%
Thrombogenesis
9%
Health Care Costs
9%
Economic Burden
9%
High Incidence
9%
Disease Pathogenesis
9%
Antisense Oligonucleotides
9%
New Therapies
9%
Primary Hepatocytes
9%
Chromatin Immunoprecipitation (ChIP)
9%
Western Hemisphere
9%
Publicly Available
9%
Gene Activation
9%
Ischemic Stroke
9%
Novel Therapeutics
9%
Disease Burden
9%
Transcriptional Activity
9%
Vascular Thrombus
9%
Chronic Phase
9%
Parasitic Diseases
9%
Mouse Infection
9%
Patient Experience
9%
Molecular Tools
9%
Neurological Disorders
9%
Disease Development
9%
Coagulation Hemostasis
9%
Isoform Expression
9%
Lost Productivity
9%
Hypercoagulability
9%
Stroke Incidence
9%
Gene Expression Level
9%
Hepatic Expression
9%
Epigenetic Marks
9%
Cultured Hepatocytes
9%
Gene Promoter
9%
Decoy
9%
Activation Level
9%
Epigenetic Signature
9%
Anti-parasite Drugs
9%
Hemophilia
9%
Anticoagulants
9%
Premature Death
9%
Etiological Factors
9%
Expression Distribution
9%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatocyte Nuclear Factor 4
100%
Chagas Disease
100%
Inflammation
100%
Trypanosoma Cruzi
36%
Blood Clotting Factor
36%
Nucleoprotein
27%
Histone
18%
Mouse Model
9%
Anticoagulant Agent
9%
Blood Stasis
9%
Hypercoagulability
9%
Thromboembolism
9%
Parasitosis
9%
Brain Ischemia
9%
Thrombophilia
9%
Prematurity
9%
Etiology
9%
Infection
9%
Thrombus
9%
Procoagulant
9%
Heart Disease
9%
Neurologic Disease
9%
Antisense Oligonucleotide
9%
Disease Course
9%
Haemophilia A
9%
Cerebrovascular Accident
9%
Medicine and Dentistry
Chagas Disease
100%
Hepatocyte Nuclear Factor 4
100%
Trypanosoma Cruzi
36%
Blood Clotting Factor
36%
Nucleoprotein
27%
Gene Expression
18%
Histone
18%
Disease Burden
9%
Hemisphere
9%
Neurologic Disease
9%
Infection
9%
Health Care Cost
9%
Hepatocyte
9%
Blood Stasis
9%
Thrombus
9%
Brain Ischemia
9%
Hypercoagulability
9%
Gene Promoter
9%
Prematurity
9%
Gene Activation
9%
Etiology
9%
Apoplexy
9%
Patient Experience
9%
Thromboembolism
9%
Blood Clotting
9%
Parasitic Disease
9%
Thrombophilia
9%
Anticoagulant
9%
Disease Course
9%
Heart Disease
9%
Procoagulant
9%
Antisense Oligonucleotide
9%
Haemophilia A
9%